NPD-1335 (Benzylalkynamide 37) is a Trypanosoma brucei phosphodiesterase B1 (TbrPDEB1) inhibitor with sub-micromolar activity against Trypanosoma brucei parasites; it exhibits an improved cytotoxicity profile and increases intracellular cAMP levels, leading to alterations in cell cycle progression and induction of cell death.